A 40‐week phase 2B randomized, multicenter, double‐blind, placebo‐controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis von Bhai, Salman, Levine, Todd, Moore, Dan, Bowser, Robert, Heim, Andrew J., Walsh, Maureen, Shibani, Aziz, Simmons, Zachary, Grogan, James, Goyal, Namita A., Govindarajan, Raghav, Hussain, Yessar, Papsdorf, Tania, Schwasinger‐Schmidt, Tiffany, Olney, Nick, Goslin, Kim, Pulley, Michael, Kasarskis, Edward, Weiss, Michael, Katz, Susan W., Moser, Suzan, Jabari, Duaa, Jawdat, Omar, Statland, Jeffrey, Dimachkie, Mazen M., Barohn, Richard

Volltext